Secretion of Vascular Endothelial Growth Factor by Primary Human Fibroblasts at Senescence
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
Cellular senescence prevents the proliferation of cells at risk for neoplastic transformation. Nonetheless, the senescence response is thought to be antagonistically pleiotropic and thus contribute to aging phenotypes, including, ironically, late life cancers. The cancer-promoting activity of senescent cells is likely due to secreted molecules, the identity of which remains largely unknown. Here, we have shown that senescent fibroblasts, much more than presenescent fibroblasts, stimulate tumor vascularization in mice. Weakly malignant epithelial cells co-injected with senescent fibroblasts had larger and greater numbers of blood vessels compared with controls. Accordingly, increased vascular endothelial growth factor (VEGF) expression was a frequent characteristic of senescent human and mouse fibroblasts in culture. Importantly, conditioned medium from senescent fibroblasts, more than medium from presenescent cells, stimulates cultured human umbilical vein endothelial cells to invade a basement membrane, a hallmark of angiogenesis. Increased VEGF expression was specific to the senescent phenotype and increased whether senescence was induced by replicative exhaustion, overexpression of p16(Ink4a), or overexpression of oncogenic RAS. The senescence-dependent increase in VEGF production was accompanied by very little increase in hypoxic-inducible (transcription) factor 1 alpha protein levels, and hypoxia further induced VEGF in senescent cells. This result suggests the rise in VEGF expression at senescence is not a hypoxic response. Our findings may in part explain why senescent cells stimulate tumorigenesis in vivo and support the idea that senescent cells may facilitate age-associated cancer development by secreting factors that promote malignant progression.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Coinjection of senescent, but not nonsenescent, fibroblasts significantly stimulated the proliferation of mouse and human epithelial tumor cells in immunocompromised mice (97, 129, 130).”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [97]
In the citing paper
“Of particular importance in this regard are the SASP components MMP3 (stromelysin) (130), which also promotes tumor cell invasion, and VEGF (97), which promotes tumor-driven angiogenesis.”
From Aging, Cellular Senescence, and Cancer (2013) · cites this paper as [97]
In the citing paper
“Initial studies focused on the pro-tumourigenic properties of the SASP 5-7 but the SASP also mediates important tumour suppressive effects 3 .”
From A complex secretory program orchestrated by the inflammasome controls paracrine senescence (2013) · cites this paper as [6]
In the citing paper
“Consequently, senescent cells can alter the tissue microenviroment and affect neighboring cells through paracrine signaling.”
From Chemokine signaling via the CXCR2 receptor reinforces senescence (2008) · cites this paper as Coppe et al., 2006
In the citing paper
“Inflammatory SASP components and accumulation of immature immunosuppressive myeloid cells in solid tumors promote tumorigenesis by driving cell migration, growth, invasion, angiogenesis and eventually metastasis (Krtolica et al., 2001; Coppé et al., 2006; Yoshimoto et al., 2013; Di Mitri et al., 2014; Eggert et al., 2016; Demaria et al., 2017; Kim Y.H. et al., 2017; Chen et al., 2018).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Coppé et al., 2006
5 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hanahan, D., & Weinberg, R. A. (2000) · Cell · doi:10.1016/s0092-8674(00)81683-9 · Cited by 29,219
A biomarker that identifies senescent human cells in culture and in aging skin in vivo.
Dimri, G. P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., Medrano, E. E., Linskens, M., Rubelj, I., & Pereira-Smith, O. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.20.9363 · Cited by 7,477
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a
Serrano, M., Lin, A. W., McCurrach, M. E., Beach, D., & Lowe, S. W. (1997) · Cell · doi:10.1016/s0092-8674(00)81902-9 · Cited by 5,218
Vascular Endothelial Growth Factor Is a Secreted Angiogenic Mitogen
Leung, D. W., Cachianes, G., Kuang, W.-J., Goeddel, D. V., & Ferrara, N. (1989) · Science · doi:10.1126/science.2479986 · Cited by 4,986
In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector
Naldini, L., Blömer, U., Gallay, P., Ory, D., Mulligan, R., Gage, F. H., Verma, I. M., & Trono, D. (1996) · Science · doi:10.1126/science.272.5259.263 · Cited by 4,903
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
Orimo, A., Gupta, P. B., Sgroi, D. C., Arenzana-Seisdedos, F., Delaunay, T., Naeem, R., Carey, V. J., Richardson, A. L., & Weinberg, R. A. (2005) · Cell · doi:10.1016/j.cell.2005.02.034 · Cited by 3,759
Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors
Campisi, J. (2005) · Cell · doi:10.1016/j.cell.2005.02.003 · Cited by 2,379
Self-citationKrtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Self-citation
Research works printed but not linked: 2
- Barcellos-Hoff, 2000, Cancer Res., 60, 1254
- Olumi, 1999, Cancer Res., 59, 5002
Cited by
Items 101–200 of 626
Senescence as a therapeutically relevant response to CDK4/6 inhibitors
Wagner, V., & Gil, J. (2020) · Oncogene · doi:10.1038/s41388-020-1354-9 · Cited by 148
Crooke, S. N., Ovsyannikova, I. G., Poland, G. A., & Kennedy, R. B. (2019) · Experimental Gerontology · doi:10.1016/j.exger.2019.110632 · Cited by 156
Senescence and the tumor-immune landscape: Implications for cancer immunotherapy
Chibaya, L., Snyder, J. T., & Ruscetti, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.02.005 · Cited by 161
The role of cellular senescence and SASP in tumour microenvironment
Takasugi, M., Yoshida, Y., Hara, E., & Ohtani, N. (2023) · The FEBS Journal · doi:10.1111/febs.16381 · Cited by 144
Cellular senescence, ageing and disease
Burton, D. G. A. (2008) · AGE · doi:10.1007/s11357-008-9075-y · Cited by 160
“Coppe et al. (2006) , for example, found that vascular endothelial growth factor (VEGF) secretion is elevated in human senescent fibroblast cultures.”
BackgroundTargeting Cardiac Stem Cell Senescence to Treat Cardiac Aging and Disease
Cianflone, E., Torella, M., Biamonte, F., De Angelis, A., Urbanek, K., Costanzo, F. S., Rota, M., Ellison-Hughes, G. M., & Torella, D. (2020) · Cells · doi:10.3390/cells9061558 · Cited by 132
“Replicative senescence is linked to a multi-component senescence-associated secretory phenotype (SASP), which is considered the second hallmark of senescence [6,7].”
BackgroundMolecular signaling and genetic pathways of senescence: Its role in tumorigenesis and aging
Zhang, H. (2007) · Journal of Cellular Physiology · doi:10.1002/jcp.20919 · Cited by 128
“Senescent cells are arrested in G1/ G0 phase of the cell cycle and do not enter S phase in response to mitogens (Sherwood et al., 1988; Cristofalo et al., 1989), in contrast with the transient and reversible nature of quiescence.”
BackgroundColucci, M., Sarill, M., Maddalena, M., Valdata, A., Troiani, M., Massarotti, M., Bolis, M., Bressan, S., Kohl, A., Robesti, D., et al. (2025) · Cancer Cell · doi:10.1016/j.ccell.2025.05.015 · Cited by 164
Cellular Interactions in the Tumor Microenvironment: The Role of Secretome
da Cunha, B. R., Domingos, C., Stefanini, A. C. B., Henrique, T., Polachini, G. M., Castelo‐Branco, P., & Tajara, E. H. (2019) · Journal of Cancer · doi:10.7150/jca.21780 · Cited by 140
“Cells in a senescent state and driven by NF-kB secrete 40-80 bioactive molecules, including pro-inflammatory interleukins and chemokines, growth and angiogenic factors, metalloproteinases and components of ECM, which act in a paracrine manner and can have both beneficial and detrimental effects [65-68].”
BackgroundMechanisms and significance of therapy-induced and spontaneous senescence of cancer cells
Mikuła-Pietrasik, J., Niklas, A., Uruski, P., Tykarski, A., & Książek, K. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03261-8 · Cited by 119
Nuclear DNA Damage as a Direct Cause of Aging
Best, B. P. (2009) · Rejuvenation Research · doi:10.1089/rej.2009.0847 · Cited by 122
Stress-induced Premature Senescence (SIPS)
SUZUKI, M., & BOOTHMAN, D. A. (2008) · Journal of Radiation Research · doi:10.1269/jrr.07081 · Cited by 126
The role of oxidative DNA damage in radiation induced bystander effect
Havaki, S., Kotsinas, A., Chronopoulos, E., Kletsas, D., Georgakilas, A. G., & Gorgoulis, V. G. (2014) · Cancer Letters · doi:10.1016/j.canlet.2014.01.023 · Cited by 134
Extracellular Vesicles as New Players in Cellular Senescence
Urbanelli, L., Buratta, S., Sagini, K., Tancini, B., & Emiliani, C. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17091408 · Cited by 122
“On the other hand, SASP components may stimulate the proliferation of surrounding cells as part of a global response, which communicate to neighbor cells their compromised state in order to stimulate tissue repair [9], as for instance the need of new vessels through the release of VEGF [27].”
BackgroundCellular senescence: a double-edged sword in cancer therapy
Xiao, S., Qin, D., Hou, X., Tian, L., Yu, Y., Zhang, R., Lyu, H., Guo, D. S., Chen, X., Zhou, C., et al. (2023) · Frontiers in Oncology · doi:10.3389/fonc.2023.1189015 · Cited by 144
“Additionally, senescent cells secrete multiple SASP factors through the paracrine pathway, including TGF-b family ligands, chemokine (C-C motif) ligand 2 (CCL2), chemokine (C-C motif) ligand 20 (CCL20), and vascular endothelial growth factor (VEGF) (Figure 1) (3).”
BackgroundInfluentialSenescent Carcinoma-Associated Fibroblasts Upregulate IL8 to Enhance Prometastatic Phenotypes
Wang, T., Notta, F., Navab, R., Joseph, J., Ibrahimov, E., Xu, J., Zhu, C.-Q., Borgida, A., Gallinger, S., & Tsao, M.-S. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0192 · Cited by 123
“Cell lines, tissue, and mouse strains This study was approved by the Research Ethics Board of the UniversityHealthNetwork (13-6377).”
BackgroundMethodCellular Senescence - its role in cancer and the response to ionizing radiation
Sabin, R. J., & Anderson, R. M. (2011) · Genome Integrity · doi:10.1186/2041-9414-2-7 · Cited by 113
“For instance, an increase in VEGF, as a result of senescent fibroblasts, has been seen to stimulate tumour vascularisation and invasion of basement membranes [118].”
BackgroundStressing the cell cycle in senescence and aging
Chandler, H., & Peters, G. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.07.005 · Cited by 119
Nanoparticle modulation of the tumor microenvironment enhances therapeutic efficacy of cisplatin
Miao, L., Wang, Y., Lin, C. M., Xiong, Y., Chen, N., Zhang, L., Kim, W. Y., & Huang, L. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.08.027 · Cited by 118
Of Flies, Mice, and Men: Evolutionarily Conserved Tissue Damage Responses and Aging
Neves, J., Demaria, M., Campisi, J., & Jasper, H. (2015) · Developmental Cell · doi:10.1016/j.devcel.2014.11.028 · Cited by 118
“Senescent cells, both mouse and human, also stimulate the growth of neighboring cells by secreting SASP factors, some of which are potent mitogens (Coppé et al., 2010b; Coppé et al., 2008).”
BackgroundMethodInfluentialSelf-citationCellular senescence: hot or what?
Evan, G. I., & di Fagagna, F. D. (2009) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2008.11.009 · Cited by 151
“We now know that senescence leads to a coordinated secretion of a large number of soluble factors [57 ,58] – the so-called secretory phenotype – and this occurs in different cell types, following different stresses, including oncogene activation [59 ].”
BackgroundThe emerging role of senescent cells in tissue homeostasis and pathophysiology
Tominaga, K. (2015) · Pathobiology of Aging & Age-related Diseases · doi:10.3402/pba.v5.27743 · Cited by 113
“Coinjection of senescent fibroblasts with mouse or human epithelial tumor cells into immunocompromised mice significantly stimulated tumor growth (106,107,110).”
BackgroundCellular senescence: a promising strategy for cancer therapy
Lee, S., & Lee, J.-S. (2019) · BMB Reports · doi:10.5483/bmbrep.2019.52.1.294 · Cited by 115
“org BMB Reports angiogenesis through VEGF production or by inducing the epithelial-to-mesenchymal transition of cancerous cells (84-86).”
BackgroundCancer Treatment-Induced Accelerated Aging in Cancer Survivors: Biology and Assessment
Wang, S., Prizment, A. E., Thyagarajan, B., & Blaes, A. H. (2021) · Cancers · doi:10.3390/cancers13030427 · Cited by 131
Besancenot, R., Chaligné, R., Tonetti, C., Pasquier, F., Marty, C., Lécluse, Y., Vainchenker, W., Constantinescu, S. N., & Giraudier, S. (2010) · PLoS Biology · doi:10.1371/journal.pbio.1000476 · Cited by 106
“MCP1 (GeneID: 6347), IL1, IL-10 (GeneID: 3586), and VEGF (GeneID: 7422) are secreted by TPO-exposed cells when compared to GM-CSF stimulated cells, cytokines previously reported to be secreted by senescent cells (Figure S1e) [30–33].”
BackgroundCellular senescence in the lung across the age spectrum
Parikh, P., Wicher, S., Khandalavala, K., Pabelick, C. M., Britt, R. D., & Prakash, Y. S. (2019) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00424.2018 · Cited by 112
“Certainly, various pathways that are important in lung development have been noted to be important in senescence as well (43, 112), but much more work in this area is required to understand how senescence can regulate the complex spatiotemporal aspects of lung development and whether senescence pathways are relevant t…”
BackgroundSenescent Cells and Their Secretory Phenotype as Targets for Cancer Therapy
Velarde, M. C., Demaria, M., & Campisi, J. (2013) · Interdisciplinary Topics in Gerontology and Geriatrics · doi:10.1159/000343572 · Cited by 112
“Further, SASP factors have been shown to promote malignant phenotypes in culture [40, 43] and tumor growth in vivo [44].”
BackgroundSelf-citationParamos-de-Carvalho, D., Jacinto, A., & Saúde, L. (2021) · eLife · doi:10.7554/elife.72449 · Cited by 111
Radiation-induced senescence: therapeutic opportunities
Kim, J. H., Brown, S. L., & Gordon, M. N. (2023) · Radiation Oncology · doi:10.1186/s13014-022-02184-2 · Cited by 119
Reshaping of the tumor microenvironment by cellular senescence: An opportunity for senotherapies
D’Ambrosio, M., & Gil, J. (2023) · Developmental Cell · doi:10.1016/j.devcel.2023.05.010 · Cited by 119
Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis
Shi, M., Liu, D., Duan, H., Shen, B., & Guo, N. (2010) · Cancer and Metastasis Reviews · doi:10.1007/s10555-010-9265-9 · Cited by 119
“Constitutive activation of NF-κB induces the expression of a variety of genes, such as Twist, zinc-finger E-box binding homeobox 1 (ZEB1), ZEB2, vimentin, matrix metalloproteinase (MMPs) and TnC, which are responsible for the acquisition of metastatic properties, and therefore enhances metastatic potential of cancer c…”
BackgroundStromal Senescence By Prolonged CDK4/6 Inhibition Potentiates Tumor Growth
Guan, X., LaPak, K. M., Hennessey, R. C., Yu, C. Y., Shakya, R., Zhang, J., & Burd, C. E. (2017) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-16-0319 · Cited by 106
“, IL6, IL8, CXCL-1, VEGF) promote the proliferation of tumor cells in vitro (8, 9, 11).”
BackgroundControl of senescence by CXCR2 and its ligands
Acosta, J. C., Loghlen, A., Banito, A., Raguz, S., & Gil, J. (2008) · Cell Cycle · doi:10.4161/cc.7.19.6780 · Cited by 106
Tripathi, U., Misra, A., Tchkonia, T., & Kirkland, J. L. (2021) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2021.111548 · Cited by 104
“Additionally, senescent fibroblasts can drive angiogenesis by secreting vascular endothelial growth factor (VEGF), promoting endothelial cell invasion and increasing vascularization [36].”
Liu, Y., Hawkins, O. E., Su, Y., Vilgelm, A. E., Sobolik, T., Thu, Y., Kantrow, S., Splittgerber, R. C., Short, S., Amiri, K. I., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201201378 · Cited by 99
“Other secreted pro-inflammatory factors have similar effects: VEGF stimulates migration, invasion and angiogenesis (Coppe et al, 2006) and GRO1(CXCL1) promotes tumour growth (Yang et al, 2006a).”
Oxidative stress in secondary osteoarthritis: from cartilage destruction to clinical presentation?
Ziskoven, C., Jäger, M., Zilkens, C., Bloch, W., Brixius, K., & Krauspe, R. (2010) · Orthopedic Reviews · doi:10.4081/or.2010.e23 · Cited by 125
“This coordinated secretion of proinflammatory molecules is a result of cellular senescence.(75) It is likely that ROS induced senescence of synovial and cartilage cells can promote the inflammatory transition of the osteoarthritic joint.”
BackgroundRPE cell senescence: A key contributor to age-related macular degeneration
Kozlowski, M. R. (2012) · Medical Hypotheses · doi:10.1016/j.mehy.2012.01.018 · Cited by 110
Beyond Tumor Suppression: Senescence in Cancer Stemness and Tumor Dormancy
Triana-Martínez, F., Loza, M. I., & Domínguez, E. (2020) · Cells · doi:10.3390/cells9020346 · Cited by 95
“MCS exhibits a physiological secretome mainly composed of HGF, TGF-β, CCL2/5, IL-6, VEGF, TSG-6, PGE2, and galectins 1/9 ([186] and reviewed in [187]), an anti-inflammatory environment protective against pro-inflammatory stimuli like INF-γ [188] or in 3D conditions [189].”
BackgroundNovel insights from a multiomics dissection of the Hayflick limit
Chan, M., Yuan, H., Soifer, I., Maile, T. M., Wang, R. Y., Ireland, A., O'Brien, J. J., Goudeau, J., Chan, L. J., Vijay, T., et al. (2022) · eLife · doi:10.7554/elife.70283 · Cited by 99
“The SASP has been shown to play a role in paracrine signaling whereby senescent cells can promote local wound healing and/or drive healthy neighboring cells into senescence ( Acosta et al., 2013 ; Coppé et al., 2006 ; Demaria et al., 2014 ; Coppé et al., 2008 ).”
Gingras, M., Beaulieu, M., Gagnon, V., Durham, H. D., & Berthod, F. (2007) · Glia · doi:10.1002/glia.20617 · Cited by 113
“Fibroblasts GLIA DOI 10.1002/glia are known to produce vascular endothelial growth factor (Berthod et al., 2006; Coppe et al., 2006; Sugihara et al., 1994), which was demonstrated to support motor nerve regeneration and to promote axonal growth and glial cell proliferation (Bearden and Segal, 2004;…”
BackgroundInfluentialExosomes as Emerging Pro-Tumorigenic Mediators of the Senescence-Associated Secretory Phenotype
Jakhar, R., & Crasta, K. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102547 · Cited by 98
Cellular senescence of renal tubular epithelial cells in acute kidney injury
Chen, J., Zhang, H., Yi, X., Dou, Q., Yang, X., He, Y., Chen, J., & Chen, K. (2024) · Cell Death Discovery · doi:10.1038/s41420-024-01831-9 · Cited by 110
“Senescent cells secrete MMP3, which in turn promotes tumor cell invasion and angiogenesis [47].”
BackgroundHubáčková, S., Kucerova, A., Michlits, G., Kyjacová, L., Reiniš, M., Korolov, O., Bártek, J., & Hodný, Z. (2015) · Oncogene · doi:10.1038/onc.2015.162 · Cited by 105
Filippi-Chiela, E. C., Silva, M. M. B. E., Thomé, M. P., & Lenz, G. (2015) · Autophagy · doi:10.1080/15548627.2015.1009795 · Cited by 98
Targeting cellular senescence in cancer and aging: roles of p53 and its isoforms
Beck, J., Turnquist, C., Horikawa, I., & Harris, C. (2020) · Carcinogenesis · doi:10.1093/carcin/bgaa071 · Cited by 92
“For example, senescent cells promote tumor-associated angiogenesis suggesting that targeting senescent cells may limit tumor progression (25,32).”
BackgroundCellular senescence in cancer: clinical detection and prognostic implications
Domen, A., Deben, C., Verswyvel, J., Flieswasser, T., Prenen, H., Peeters, M., Lardon, F., & Wouters, A. (2022) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-022-02555-3 · Cited by 94
The redox-senescence axis and its therapeutic targeting
Ngoi, N. Y., Liew, A. Q., Chong, S. J. F., Davids, M. S., Clement, M.-V., & Pervaiz, S. (2021) · Redox Biology · doi:10.1016/j.redox.2021.102032 · Cited by 88
“Firstly, SAS factors released by the senescent tumor cells promote cell growth, angiogenesis and immune evasion [11,12,42,43,54,59].”
BackgroundMilillo, C., Aruffo, E., Carlo, P. D., Patruno, A., Gatta, M., Bruno, A., Dovizio, M., Marinelli, L., Dimmito, M. P., di Giacomo, V., et al. (2024) · Frontiers in Public Health · doi:10.3389/fpubh.2024.1385387 · Cited by 94
“…other typical features characterize senescent cells, including the senescence-associated β -galactosidase activity (SA-β -Gal) and the secretion of a vast spectrum of cytokines, chemokines, proteases, and growth factors, referred to as senescence-associated secretory phenotype (SASP) (40, 41).”
BackgroundInfluentialLawrenson, K., Grun, B., Benjamin, E., Jacobs, I. J., Dafou, D., & Gayther, S. A. (2010) · Neoplasia · doi:10.1593/neo.91948 · Cited by 90
“The induction of senescence induces a senescence-associated secretory phenotype; senescent fibroblasts secrete a multitude of growth factors (including vascular endothelial growth factor), extracellular matrix proteins, proteases, chemokines, and cytokines [14,15].”
BackgroundNoncoding RNA control of cellular senescence
Abdelmohsen, K., & Gorospe, M. (2015) · WIREs RNA · doi:10.1002/wrna.1297 · Cited by 90
Cellular Senescence in the Development and Treatment of Cancer
Saretzki, G. (2010) · Current Pharmaceutical Design · doi:10.2174/138161210789941874 · Cited by 87
Regulation of senescence escape by TSP1 and CD47 following chemotherapy treatment
Guillon, J., Petit, C., Moreau, M., Toutain, B., Henry, C., Roché, H., Bonichon-Lamichhane, N., Salmon, J. P., Lemonnier, J., Campone, M., et al. (2019) · Cell Death & Disease · doi:10.1038/s41419-019-1406-7 · Cited by 90
Senescence-Associated MicroRNAs
Munk, R. B., Panda, A. C., Grammatikakis, I., Gorospe, M., & Abdelmohsen, K. (2017) · International review of cytology · doi:10.1016/bs.ircmb.2017.03.008 · Cited by 98
“…HCC4), cytokines (IL6, IL1A, IL1B, and IL7), MMPs (including MMP1/3/10, TIMP1/2), and additional factors (e.g., VEGF, EGF, IGFBP2, NGF, and FGF7) that influence both the immediate cellular microenvironment and distant tissues and organs (Campisi, 2005; Coppe et al., 2006; Kuilman and Peeper, 2009).”
BackgroundA Role for CXCR2 in Senescence, but What about in Cancer?
Acosta, J. C., & Gil, J. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3772 · Cited by 89
“growth factor secreted by senescent fibroblast can promote angiogenesis (11).”
BackgroundColucci, M., Zumerle, S., Bressan, S., Gianfanti, F., Troiani, M., Valdata, A., D’Ambrosio, M., Pasquini, E., Varesi, A., Cogo, F., et al. (2024) · Cancer Cell · doi:10.1016/j.ccell.2024.02.004 · Cited by 93
Consequences of mitotic slippage for antimicrotubule drug therapy
Cheng, B., & Crasta, K. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0147 · Cited by 93
Non-cell autonomous effects of the senescence-associated secretory phenotype in cancer therapy.
Saleh, T., Tyutynuk-Massey, L., Cudjoe, E. K., Idowu, M. O., Landry, J. W., & Gewirtz, D. A. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00164 · Cited by 85
“Moreover, senescent fibroblasts promote angiogenesis, which is essential for tumor growth and sustainability (58).”
BackgroundDemidenko, Z. N., & Blagosklonny, M. V. (2009) · Aging · doi:10.18632/aging.100115 · Cited by 81
“Another hallmark of cellular overactivation in senescent cells is hyper-secretory and proinflammatory phenotype, characterized by production of cytokins, mitogens and proteases [19-26].”
BackgroundExploiting tumor cell senescence in anticancer therapy
Lee, M., & Lee, J.-S. (2014) · BMB Reports · doi:10.5483/bmbrep.2014.47.2.005 · Cited by 83
“escent human fibroblasts permanently lose their differentiated properties, become invasive, undergo neoplastic transformation, and stimulate tumor vascularization (46, 48-51).”
BackgroundBuhl, J. L., Selt, F., Hielscher, T., Guiho, R., Ecker, J., Sahm, F., Ridinger, J., Riehl, D., Usta, D., Ismer, B., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-1965 · Cited by 84
“Some secreted cytokines are proangiogenic and thereby can enhance growth of neighboring cells (21, 22).”
BackgroundSuppression of p16 alleviates the senescence-associated secretory phenotype
(2021) · doi:10.18632/aging.202640 · Cited by 84
Cellular senescence: a hitchhiker’s guide
Aravinthan, A. (2015) · Human Cell · doi:10.1007/s13577-015-0110-x · Cited by 72
“Senescent cells have also been shown to stimulate tumour vascularization through secretion of VEGF [163].”
BackgroundMitochondrial DNA damage induces apoptosis in senescent cells
Laberge, R.-M., Adler, D., DeMaria, M., Mechtouf, N., Teachenor, R., Cardin, G. B., Desprez, P.-Y., Campisi, J., & Rodier, F. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.199 · Cited by 82
Self-citationCellular Plasticity: A Route to Senescence Exit and Tumorigenesis
De Blander, H., Morel, A.-P., Senaratne, A. P., Ouzounova, M., & Puisieux, A. (2021) · Cancers · doi:10.3390/cancers13184561 · Cited by 72
Therapeutic targeting of replicative immortality
Yaswen, P., MacKenzie, K. L., Keith, W. N., Hentosh, P., Rodier, F., Zhu, J., Firestone, G. L., Matheu, A., Carnero, A., Bilsland, A. E., et al. (2015) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.03.007 · Cited by 97
Bhat, T. A., Nambiar, D. K., Tailor, D., Pal, A., Agarwal, R., & Singh, R. P. (2013) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-13-0209 · Cited by 82
“VEGF stimulates blood vessel formation both in vitro and in vivo (35, 36, 39, 40).”
BackgroundShort-term gain, long-term pain: the senescence life cycle and cancer
Chan, A. S. L., & Narita, M. (2019) · Genes & Development · doi:10.1101/gad.320937.118 · Cited by 80
“The SASP also modulates other key hallmarks of cancers through locally facilitating vascularization (Coppé et al. 2006), epithelial-mesenchymal transition (Coppé et al. 2008; Kuilman et al. 2008), tumor invasion (Kim et al. 2017; He et al. 2018), and cellular plasticity (Ritschka et al. 2017).”
BackgroundSenescent Peritoneal Mesothelial Cells Promote Ovarian Cancer Cell Adhesion
Książek, K., Mikuła‐Pietrasik, J., Korybalska, K., Dworacki, G., Jörres, A., & Witowski, J. (2009) · American Journal Of Pathology · doi:10.2353/ajpath.2009.080613 · Cited by 85
Lin, P. P. (2020) · Cells · doi:10.3390/cells9061539 · Cited by 83
“Besides tumor cells, the pro-angiogenic SASP VEGF is also secreted from senescent fibroblasts [124].”
BackgroundAging, cell senescence, the pathogenesis and targeted therapies of intervertebral disc degeneration
Xu, J., Shao, T., Lou, J., Zhang, J., & Xia, C. (2023) · Frontiers in Pharmacology · doi:10.3389/fphar.2023.1172920 · Cited by 90
“The inflammatory mediators of SASP are powerful drivers of tumor progression, and early studies have shown that SASP can increase tumor angiogenesis and promote malignant cell proliferation and metastasis (Krtolica et al., 2001; Coppé et al., 2006).”
BackgroundKameda, M., Shingo, T., Takahashi, K., Muraoka, K., Kurozumi, K., Yasuhara, T., Maruo, T., Tsuboi, T., Uozumi, T., Matsui, T., et al. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05776.x · Cited by 84
“…groups: (i) the transplanted NSPCs and fibroblast cells secreted trophic factors such as NGF and GDNF (NSPCs), or vascular endothelial growth factor (fibroblast cells; Coppe et al., 2006); and (ii) endogenous NSPCs in the subventricular zone were activated after ischemia (Schmidt & Reymann, 2002).”
BackgroundReview of Major Theories of Skin Aging
Gragnani, A., Cornick, S. M., Chominski, V., Ribeiro de Noronha, S. M., Alves Corrêa de Noronha, S. A., & Ferreira, L. M. (2014) · Advances in Aging Research · doi:10.4236/aar.2014.34036 · Cited by 73
“Common features of the senescent phenotype, which can potentially be detrimental to the tissues in which they reside, are the up-regulation of growth factors, extracellular matrix (ECM)-degrading proteins and pro-inflammatory cytokines [57] [58].”
BackgroundChung, B. K., Karlsen, T. H., & Folseraas, T. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.08.020 · Cited by 81
“SASP in PSC is associated with the robust secretion of cytokine/chemokines (IL-6, IL-8, CCL2, PAI-1), various growth factors and matrix metalloproteases (MMPs) that trigger endothelial cell invasion [144] and promote tumorigenesis in models of epithelial cancer [145,146].”
BackgroundSenescence-induced endothelial phenotypes underpin immune-mediated senescence surveillance
Yin, K., Patten, D., Gough, S., de Barros Gonçalves, S., Chan, A., Olan, I., Cassidy, L., Poblocka, M., Zhu, H., Lun, A., et al. (2022) · Genes & Development · doi:10.1101/gad.349585.122 · Cited by 73
Liu, Y., Lomeli, I., & Kron, S. J. (2024) · Cells · doi:10.3390/cells13151281 · Cited by 77
“Other SASP factors implicated in angiogenesis include vascular endothelial growth factor (VEGF) and connective tissue growth factor (CTGF) [287,288].”
BackgroundTime-dependent replicative senescence vs. disturbed flow-induced pre-mature aging in atherosclerosis
Dominic, A., Banerjee, P., Hamilton, D. J., Le, N., & Abe, J. (2020) · Redox Biology · doi:10.1016/j.redox.2020.101614 · Cited by 77
“senescent cells with ‘distinct SASP’ features produce numerous inflammatory factors [146], growth factors [147], ROS [113,148,149], and promote cell growth [96], and inflammation-related [150] signaling, eventually leading to a more aggressive proliferative phenotype by”
BackgroundPremature aging/senescence in cancer cells facing therapy: good or bad?
Calvo, L., Ghadaouia, S., Martinez, A., & Rodier, F. (2015) · Biogerontology · doi:10.1007/s10522-015-9593-9 · Cited by 82
Mária, J., & Ingrid, Ž. (2017) · Food & Function · doi:10.1039/c7fo00161d · Cited by 71
Towards precision medicine using biochemically triggered cleavable conjugation
Parshad, B., Arora, S., Singh, B., Pan, Y., Tang, J., Hu, Z., & Patra, H. K. (2025) · Communications Chemistry · doi:10.1038/s42004-025-01491-5 · Cited by 72
Verona, E. V., Elkahloun, A. G., Yang, J., Bandyopadhyay, A., Yeh, I.-T., & Sun, L.-Z. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-0444 · Cited by 71
DOT1L modulates the senescence-associated secretory phenotype through epigenetic regulation of IL1A
Leon, K. E., Buj, R., Lesko, E., Dahl, E. S., Chen, C.-W., Tangudu, N. K., Imamura-Kawasawa, Y., Kossenkov, A. V., Hobbs, R. P., & Aird, K. M. (2021) · Journal of Cell Biology · doi:10.1083/jcb.202008101 · Cited by 70
“(Coppé et al., 2006; Ritschka et al., 2017; Sparmann and Bar-Sagi, 2004).”
Wang, F., Li, Z., Chen, L., Yang, T., Liang, B., Zhang, Z., Shao, J., Xu, X., Yin, G., Wang, S., et al. (2022) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2022.03.014 · Cited by 75
Secretome of Senescent Adipose-Derived Mesenchymal Stem Cells Negatively Regulates Angiogenesis
Ratushnyy, A. Y., Ездакова, М. И., & Buravkova, L. B. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051802 · Cited by 76
“So, it be found most, but not all, human and mouse fibroblast strains secrete biologically active VEGF at senescence [42].”
BackgroundRegulation of senescence escape by the cdk4–EZH2–AP2M1 pathway in response to chemotherapy
Le Duff, M., Gouju, J., Jonchère, B., Guillon, J., Toutain, B., Boissard, A., Henry, C., Guette, C., Lelièvre, E., & Coqueret, O. (2018) · Cell Death & Disease · doi:10.1038/s41419-017-0209-y · Cited by 64
The versatile role of exosomes in cancer progression: diagnostic and therapeutic implications
Sundararajan, V., Sarkar, F. H., & Ramasamy, T. S. (2018) · Cellular Oncology · doi:10.1007/s13402-018-0378-4 · Cited by 67
Lee, S. Y., Ju, M. K., Jeon, H. M., Lee, Y. J., Kim, C. H., Park, H. G., Han, S. I., & Kang, H. S. (2018) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2018/1027453 · Cited by 71
Telomeres and Cancer: Resolving the Paradox
Nassour, J., Schmidt, T. T., & Karlseder, J. (2021) · Annual Review of Cancer Biology · doi:10.1146/annurev-cancerbio-050420-023410 · Cited by 75
“Downregulation of cytoplasmic DNases is implicated in cytoplasmic DNA accumulation and SASP in senescent cells.”
BackgroundInfluentialNegahdari, S., Galehdari, H., Kesmati, M., Rezaie, A., & Shariati, G. (2017) · International Journal of Preventive Medicine · doi:10.4103/ijpvm.ijpvm_338_16 · Cited by 78
“Coppé et al.[11] reported that hypoxia is a characteristic of wound that increases VEGF expression in different cells such as fibroblasts, keratinocytes, myocytes, and endothelial cells.”
Alessio, N., Aprile, D., Squillaro, T., Bernardo, G. D., Finicelli, M., Melone, M. A. B., Peluso, G., & Galderisi, U. (2019) · Aging · doi:10.18632/aging.102172 · Cited by 69
“Some investigations showed that the SASP released by senescent fibroblasts may promote cancer [5-10].”
BackgroundSenescent stromal cells: roles in the tumor microenvironment
Gabai, Y., Assouline, B., & Ben‐Porath, I. (2022) · Trends in cancer · doi:10.1016/j.trecan.2022.09.002 · Cited by 68
The Emerging Role of Senescence in Ocular Disease
Sreekumar, P. G., Hinton, D. R., & Kannan, R. (2020) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2020/2583601 · Cited by 61
“For example, out of the SASPs, IL-6, IL-8, and CCL2 enhance tumor cell proliferation [14, 121]; VEGF promotes angiogenesis [122]; IL-6, IL-8, IGFBP7, and PAI-1 augment senescence [119–124].”
BackgroundBlagosklonny, M. V. (2008) · Rejuvenation Research · doi:10.1089/rej.2008.0722 · Cited by 67
“26 33 In aging organisms, cellular hyperplasia and hypertrophy (increased cell proliferation and cell size growth, respectively) are manifest as benign tumors, cancers, atherosclerotic plaques, cardiac hypertrophy, fibrosis, and enlarged fat tissue.”
Dańczak‐Pazdrowska, A., Gornowicz‐Porowska, J., Polańska, A., Krajka‐Kuźniak, V., Stawny, M., Gostyńska, A., Rubiś, B., Noureddine, S. A., Ashiqueali, S., Schneider, A., et al. (2023) · Aging Cell · doi:10.1111/acel.13845 · Cited by 71
“However, it has also been suggested that proangiogenic, proinflammatory growth factors as well as metalloproteinases released by persistent senescent cells may exert tumor- promoting effects (Alimirah et al., 2020; Coppe et al., 2006; Coppe, Boysen, et al., 2008; Coppe, Patil, et al., 2008).”
BackgroundKsiążek, K., Mikuła‐Pietrasik, J., Catar, R. A., Dworacki, G., Winckiewicz, M., Frydrychowicz, M., Dragun, D., Staniszewski, R., Jörres, A., & Witowski, J. (2009) · International Journal of Cancer · doi:10.1002/ijc.25036 · Cited by 67
Was, H., Barszcz, K., Czarnecka, J., Kowalczyk, A., Bernas, T., Uzarowska, E., Koza, P., Klejman, A., Piwocka, K., Kaminska, B., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.14066 · Cited by 61
“VEGF is produced by normal senescent fibroblasts and enhances angiogenesis in tumors [66].”
BackgroundZhou, L., Zheng, D., Wang, M., & Cong, Y. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.06.116 · Cited by 62
“The normal human embryonic lung cells WI-38, which have undetectable telomerase activity but express low levels of VEGF [30], were transiently transfected with the hTERT expression vector pcDNA-hTERT, and levels of VEGF165 and hTERT mRNAs were determined by semi-quantitative PCR and quantitative real-time PCR at diffe…”
MethodSenescence and cancer: An evolving inflammatory paradox
Ruhland, M. K., Coussens, L. M., & Stewart, S. A. (2016) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2015.10.001 · Cited by 60
“Growth of tumors is further supported through increased angiogenesis derived from heightened expression of SASP factor vascular endothelial growth factor (VEGF) (56).”
Bientinesi, E., Lulli, M., Becatti, M., Ristori, S., Margheri, F., & Monti, D. (2022) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2022.111689 · Cited by 61
Regulation of Senescence in Cancer and Aging
Kong, Y., Cui, H., Ramkumar, C., & Zhang, H. (2011) · Journal of Aging Research · doi:10.4061/2011/963172 · Cited by 69
“[15] J.”
Minieri, V., Saviozzi, S., Gambarotta, G., Iacono, M. L., Accomasso, L., Rocchietti, E. C., Gallina, C., Turinetto, V., & Giachino, C. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12387 · Cited by 70
“Senescence-associated secretory phenotype has been shown to promote the proliferation of pre-malignant and malignant epithelium [60], enhance invasion [61], induce an epithelial to mesenchymal transition in carcinoma cells [62], increase the growth of xenograft tumours in vivo [63] and mediate paracrine transmission o…”
Background
Metadata
- Authors
- Coppé, J.-P., Kauser, K., Campisi, J., & Beauséjour, C. M.
- Affiliations
- Lawrence Berkeley National Laboratory (US)
- Buck Institute for Research on Aging (US)
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2006-10
- Volume
- 281
- Issue
- 40
- Pages
- 29568-29574
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2085498425
- Semantic Scholar
- d07db27e4b9c1c7084c39e42be0beb339e87b5ad
- Cited by
- 604
- References
- 38
- Citations by year
- 2026: 15 · 2025: 29 · 2024: 45 · 2023: 37 · 2022: 49 · 2021: 47 · 2020: 46 · 2019: 38 · 2018: 32 · 2017: 30 · 2016: 19 · 2015: 34 · 2014: 27 · 2013: 21 · 2012: 24
- FWCI
- 14.56
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 5115 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Funders
- National Institute on Aging (AG-09909)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › TGF-β signaling in diseases
- Keywords
- cellular senescence, vascular endothelial growth factor, senescence-associated secretory phenotype, tumor vascularization, angiogenesis, fibroblasts, replicative senescence, p16INK4a, oncogenic Ras, hypoxia-inducible factor-1α, hypoxia, tumor microenvironment, aging and cancer
- MeSH terms
- Adult, Animals, Cell Transformation, Neoplastic, Cells, Cultured, Fibroblasts, Humans, Mammary Neoplasms, Experimental, Mice, Nude, Neoplasm Invasiveness, Neovascularization, Pathologic, Cellular Senescence, Culture Media, Conditioned, Vascular Endothelial Growth Factor A, Cell Line, Tumor, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.